Key End Points for Providers to Consider With New Multiple Myeloma Therapies: Hearn Jay Cho, MD, PhD
Hearn Jay Cho, MD, PhD, chief medical officer at the Multiple Myeloma Research Foundation, shared insights on what end points ...
The perfect way to get in that holiday spirit, but with a caveat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback